This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1tdl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1tdl.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1tdl.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1tdl| PDB=1tdl | SCENE= }}
{{STRUCTURE_1tdl| PDB=1tdl | SCENE= }}
-
'''Structure of Ser130Gly SHV-1 beta-lactamase'''
+
===Structure of Ser130Gly SHV-1 beta-lactamase===
-
==Overview==
+
<!--
-
A bacterial response to the clinical use of class A beta-lactamase inhibitors such as tazobactam and clavulanic acid is the expression of variant beta-lactamases with weaker binding affinities for these mechanism-based inhibitors. Some of these inhibitor-resistant variants contain a glycine mutation at Ser130, a conserved active site residue known to be adventitiously involved in the inhibition mechanism. The crystallographic structure of a complex of tazobactam with the Ser130Gly variant of the class A SHV-1 beta-lactamase has been determined to 1.8 A resolution. Two reaction intermediates are observed. The primary intermediate is an acyclic species bound to the reactive Ser70. It is poorly primed for catalytic hydrolysis because its ester carbonyl group is completely displaced from the enzyme's oxyanion hole. A smaller fraction of the enzyme contains a Ser70-bound aldehyde resulting from hydrolytic loss of the triazoyl-sulfinyl amino acid moiety from the primary species. This first structure of a class A beta-lactamase lacking Ser130, the side chain of which functions in beta-lactam binding and possibly in catalysis, gives crystallographic evidence that the acylation step of beta-lactam turnover can occur without Ser130. Unexpectedly, the crystal structure of the uncomplexed Ser130Gly enzyme, also determined to 1.8 A resolution, shows that a critical Glu166-activated water molecule is missing from the catalytic site. Comparison of this uncomplexed variant with the wild-type structure reveals that Ser130 is required for orienting the side chain of Ser70 and ensuring the hydrogen bonding of Ser70 to both Lys73 and the catalytic water molecule.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15518561}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15518561 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15518561}}
==About this Structure==
==About this Structure==
Line 32: Line 36:
[[Category: Drug design]]
[[Category: Drug design]]
[[Category: Penicillinase]]
[[Category: Penicillinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 09:49:42 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 23:36:32 2008''

Revision as of 20:36, 28 July 2008

Image:1tdl.png

Template:STRUCTURE 1tdl

Structure of Ser130Gly SHV-1 beta-lactamase

Template:ABSTRACT PUBMED 15518561

About this Structure

1TDL is a Single protein structure of sequence from Klebsiella pneumoniae. Full crystallographic information is available from OCA.

Reference

Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant., Sun T, Bethel CR, Bonomo RA, Knox JR, Biochemistry. 2004 Nov 9;43(44):14111-7. PMID:15518561

Page seeded by OCA on Mon Jul 28 23:36:32 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1tdl"
Personal tools